pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-1343 |
Genomic Coordinates | chr11: 34941837 - 34941920 |
Description | Homo sapiens miR-1343 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-1343-5p | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequence | 15| UGGGGAGCGGCCCCCGGGUGGG |36 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Experiments | Illumina | DRVs in miRNA |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | RGS6 | ||||||||||||||||||||
Synonyms | GAP, HA117, S914 | ||||||||||||||||||||
Description | regulator of G protein signaling 6 | ||||||||||||||||||||
Transcript | NM_004296 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on RGS6 | |||||||||||||||||||||
3'UTR of RGS6 (miRNA target sites are highlighted) |
>RGS6|NM_004296|3'UTR 1 CCGTTCCTACCGCAGGTCCAGGGCCTGGGCCCGCGGACCCCACAGGCAGGCGGCGGCGCTCCACATCTGCGGACAGAGTT 81 TCCTTACGAGGAGACTTGGTCACTGTGAAGGAGAAAGAGTGAGGGCAATGAAGGGCGATGGTGGGGAGACTCGGTGGGTG 161 AATGGGGAGACCAGAAAGAAAGAGTCCACAGAGCCTGGGCTGGGCCCGGTGGAGGCTCCTGTTTACAGCCCTCTCTTCTT 241 TGTACAGTTGTATTCCAACACTCCACTCGCTAAGAGGCCCTGATCCCAGCTCATTCAGGGGAGAACACGTCGTGGGGTTC 321 CTGTCACGACTATCACTTGAGATTATATTATTATCCTCACTCCCTCGCTGTCTGGAGACGGTCACACCTTCTGGCAAATT 401 CAAGAGGCATGAGTGGACCGAGAGCACATCCAGCATTTGCATCACCTCCCTGGCACCTCCCATAGTTACAGCCACTACAT 481 CCCCACCGCCGCCTGTCATCCCTCACGTCTCTGTGGCCACCCGGGTGTCACTGCCAGCACCAGGCACTGCTTTCACGTAA 561 AATGTCCAAATCACATCTTCAGCAAGAAAGCAACCTCACGGATTGCCCCGCCTCAAGGTCTTTCCACCCTCTTTGAGATC 641 AGCGTTCGGAGAGGTCCCCGCCAGCCCGGTGGCTGCCCTCAGGTCCCGTCACATGTCTCAAGGGTCCAGCGTTCGAGGAA 721 GCACTGTTGTAGATGACAGAGCTTTTTGTTTCACAGCTGCGGGGATTCTGCTGACCATCTTTTAGAAAATTATTTCATAA 801 TTTATTCTGGCTTTGCCCCCTTGCTCCTTGGTTTATTCCCTCATGTTTTACTCAAAATAAACATGGCCATGAACTCAGGG 881 GCCATTGGGATTCTCCCCTCTGGCAGCCCCAGGTGGGAGCTGGGAGGGTCCCCAGCCCAGGAGGTGGCTGGATTGCAGGG 961 CTGGCAGCCCCCACGTGGTGGCATCCTGACAGGCACAGTGAGACCCTTGCTGGGTCAGGTCTCCTTTGTGTGTGAAGCTG 1041 GGGCAGAGTATGCTACGAAGGGACCAGGCCAGGCCACAGGGCTCTCCTCCCAGTCTTTATCTGAAGGCCCAGCCAAAGCA 1121 CCCCTCTAAACCGGTCACCTAGGGGAAATGCAAAAACCTGCAAAAGATCCACCTGTATTCCCTGTGTGTGTGTGTCAAAA 1201 TGACCATTTGCCAACCTGGCTGTGAGGTAATGTATGTAAAGCACCGAGTCAGGTGCCTGATACGCAGTAGGTGCTTAGCA 1281 AACGGTAGCTAATACTATCATCATTGTCATTGTTATTGTGACACCCATGAGCCCACAGACAGAGCTGTATTAAGTAACCT 1361 GTTTTGAATCCAGACATTCACTCCCCCACTTGCTATGACTACCCTCCTTTGATCTATTTTTGGTCATAGGTAAAAAAAAA 1441 AATCTCTCTTGGGAGCATATAAACAAAAAACATAGAAGCAATAAAGCGATCGCTGGTATTTCTTTTCTCATGCAGCCAAA 1521 TTCGCCAGCTGGTGACCAAAGGCTCAGATGCTTGCTTATTTGCAGACCCGGCCTCCTGGGTGCTCCCCAGTGACCCATCT 1601 TTCCACCCCACCACCTCCAAGTCCTGTCTATGTCTGCTTCCACACAGCCCTGTCCCCAGGGCACCAGCCTTCTGTCCCTC 1681 ACAGCAGTGCCATCGCGGGCATTAGGAGTCTTCGTTATGTTGTATCCTTGTGAGTTCTTGACTACCATGCCCAAGTTTCC 1761 CCCACTGGCAATGGTTCCTCTCTTGGAGGTACAGTGGAAACCAGAGAGATGACAGATGTTGAGTCCTCAGTGTCTCAGAG 1841 GCAGCAATTCTTGCTGGACACCTGCACATGCTCAGCACAGAGGCTGGTACTTTGGAGGCACTAACCACTTGATGAGTAAA 1921 TCAATGGCATAAAGCCCCATTCCAAGTTATGGGGTCTTTTGACAGGCCCCTTTCATCCTCTTTCTCTTTGTATAAACCTC 2001 ATGTTTCAGAACAAAATTACAGTCTAAGTTCATTTGCCCCCAGCCTTGCCCAAGGATCCCCGGGCTGTGCTGACCCCTAG 2081 GCATAGGGCAAAGGGTGTTCCCAAGCAGCAGGCACCTCAGTGCCCTCAGTTATCCAGGGCAAGGGGCCTGGCTGCCCCCT 2161 GCTCCTCCCCATGATGCAGGGGCTTTCTAAGCCAGGCTGCAGACAGGGCAGGGTTGGCTTCTTGGCCATTCCCTCTGTGC 2241 CCCCTTCTCCTTCTGACTGGTCTCACCCTGGAGATCCCCAGAGGATCTGACCAGAGCCAGGTGGACTGTGGCCCTGAGAT 2321 GGAGCTGGCTGCAGGCTTACAAGCACCTCTGGGGACATCCAGAGGGGAGGGTCAGTAAGCACAACGGAGCTAGGGAGACT 2401 TCAGATGGACTCAAACCCAGAGCAATAATACTCTCACACCACCCCACAGCTAAGGCACTCATGTTCCCCAGTAGATCAAG 2481 CCAGAAGCTTTGCAAGAAGGGAGTGGAACGAGGCTGCCTATCCAAGGTCCATCTACCACGCAGAACTTGGTCATGCAAGT 2561 ACATTTGGAAAATCTGGTCTTGGCCCGTCCCCCATTGGCCTGGTCTACACAGCCAAAAATTCAGACTAGATTAGATGTTT 2641 GCAGGCAATTCTGTAGCAAAGCAAATTCCCCTACCCCGTCCCTTCCCCCTAGAAGCTGCCTTAGCCTCCCTGACTGGGTG 2721 TGGTCTCTGGGCCTAGGACTCCTCCCTATGAGGAAAAGTGCTCTCCAGCCACATCTTGGCAGCCCCACAACCACAGCATC 2801 AGGGCAGCTGCAGCAAGTGACCACCCACCCGTCGGGTTAGACACACAAGGCACCAGGCACTGGCATCTGACTAAAATAAC 2881 CTTTCCCTACATGGGAAGAGGAAAGCTTGTAGGCTGGCACATATAAACGTCCAGCCGCAGCCAGATGGCCTGAACTAAGC 2961 AGCAGGAACTCTCTGGGCTGGGGAGGAGCCTCCTGCCCTTCTAGAAAGTGATGCGTCAGCTTTGTTCTCCTGGGAAGGTG 3041 TTGCTATACCCCAGGAACAAAGCAGGGCCCAACTGCCAGTGCAGTCAGCTGGGCCTGCGCTCCAGGCTCACCACCGCTAA 3121 GTGGTCAGGTACCGGGCCAGCATCCTGGGAGGGACCTCTTGCGACTCTGAGTTGCAGCTTGGACTAGCTGAACACATGGG 3201 GACATGCTCCAGGGGCTTCTTCCCTGGCAGGATTCCTGGGATTTCAAACTACCTCACCAACAGGACGCTGAACCAGGAGC 3281 CTGCCACCCAACTGGCCCCCTTGGTGATTGTGGAAGGTGATGTTTTTCCTAAAATGCATCCCTCCTGTTCTGCTCCATAT 3361 ACATGTGCTTCAAAAACCACCACCAGGAAAGCCTTCCCAGAAGAGGGAAAGGATTAAGGGCTCTCTTCCTTTGGGCCCTG 3441 CAGAATGTATTGGAGGGAGGTGTTGCTGCAAGGTCCAGGAGCTGGGAAACTCTGGGCTCGGGGGGAGATAATGCACCACC 3521 AGCCTCAAAAAGGAGCTGCCCAAGTTGAATATGTAGCAAAGACCATGGGATAAGTTGAATAGTGGCCAGACGAATCACTA 3601 ATAACTCACCATGGGACCCTCTGAAGAGAGGCCTGTGCTCGTGTAACCATAGCAACAGCAGATGCCAGCAACCTACTCAT 3681 TAGTACCACCCAGTGATAAGGCATCCCCTGGGCTAGACCCAGGGGCCATAAAGTAGCAAAGTAGCAAATGTAGCAATAAA 3761 GGGCCCGGGTCTATACGGGGACAGGGTCCAAATGACCAGGACTTGGCCCTCTCCCCAGCCCCGATGAGGGCTCAGAGCCA 3841 GCTGCTGTCAGCTGTCTGGGGAGGGAAGGCCCTGCTCCATACCAGGGGTCCCTGTTCTATACTCTAAGCCCACTCACCGC 3921 ATGATCACGGACTCATCGGAATGGCCTCCTCTTAGTGCATGTGGTTCTCTTTAGTTTATTTTTCTGGAATTTGGGGATTG 4001 GACCCCAGAACCAAACATGCTGGTACAGTCTAAAAATAAATGACTTGAACCCACTTCAATCCAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | BC-3 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM796039. RNA binding protein: AGO2. Condition:4-Thiouridine
... - Gottwein E; Corcoran DL; Mukherjee N; et al., 2011, Cell host & microbe. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Gottwein E; Corcoran DL; Mukherjee N; et al. - Cell host & microbe, 2011
Primary effusion lymphoma (PEL) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) and frequently also harbors Epstein-Barr virus (EBV). The expression of KSHV- and EBV-encoded microRNAs (miRNAs) in PELs suggests a role for these miRNAs in latency and lymphomagenesis. Using PAR-CLIP, a technology which allows the direct and transcriptome-wide identification of miRNA targets, we delineate the target sites for all viral and cellular miRNAs expressed in PEL cell lines. The resulting data set revealed that KSHV miRNAs directly target more than 2000 cellular mRNAs, including many involved in pathways relevant to KSHV pathogenesis. Moreover, 58% of these mRNAs are also targeted by EBV miRNAs, via distinct binding sites. In addition to a known viral analog of cellular miR-155, we show that KSHV encodes a viral miRNA that mimics cellular miR-142-3p function. In summary, this study identifies an extensive list of KSHV miRNA targets, which are likely to influence viral replication and pathogenesis.
LinkOut: [PMID: 22100165]
|
CLIP-seq Support 1 for dataset GSM796039 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-3 / 4-Thiouridine |
Location of target site | ENST00000553530.1 | 3UTR | UUGGCCCUCUCCCCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
129 hsa-miR-1343-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT168710 | CDKN1A | cyclin dependent kinase inhibitor 1A | 2 | 2 | ||||||||
MIRT189773 | CDADC1 | cytidine and dCMP deaminase domain containing 1 | 2 | 2 | ||||||||
MIRT443841 | RGS6 | regulator of G protein signaling 6 | 2 | 2 | ||||||||
MIRT446199 | GTPBP4 | GTP binding protein 4 | 2 | 2 | ||||||||
MIRT448038 | SFRP1 | secreted frizzled related protein 1 | 2 | 2 | ||||||||
MIRT451305 | LGALS3BP | galectin 3 binding protein | 2 | 2 | ||||||||
MIRT452320 | EIF5AL1 | eukaryotic translation initiation factor 5A-like 1 | 2 | 2 | ||||||||
MIRT453238 | FTSJ3 | FtsJ RNA methyltransferase homolog 3 | 2 | 2 | ||||||||
MIRT453500 | ARRB1 | arrestin beta 1 | 2 | 2 | ||||||||
MIRT453540 | PRR12 | proline rich 12 | 2 | 2 | ||||||||
MIRT454900 | SEPT8 | septin 8 | 2 | 16 | ||||||||
MIRT456443 | TMEM81 | transmembrane protein 81 | 2 | 2 | ||||||||
MIRT456683 | LDB1 | LIM domain binding 1 | 2 | 2 | ||||||||
MIRT457129 | ASPH | aspartate beta-hydroxylase | 2 | 2 | ||||||||
MIRT457178 | ERC1 | ELKS/RAB6-interacting/CAST family member 1 | 2 | 2 | ||||||||
MIRT457598 | IDS | iduronate 2-sulfatase | 2 | 2 | ||||||||
MIRT458304 | TNFAIP8L3 | TNF alpha induced protein 8 like 3 | 2 | 2 | ||||||||
MIRT458442 | RPRM | reprimo, TP53 dependent G2 arrest mediator homolog | 2 | 2 | ||||||||
MIRT460645 | IGFBP4 | insulin like growth factor binding protein 4 | 2 | 2 | ||||||||
MIRT461455 | SLC19A3 | solute carrier family 19 member 3 | 2 | 2 | ||||||||
MIRT462768 | ZNF8 | zinc finger protein 8 | 2 | 2 | ||||||||
MIRT462990 | ZNF740 | zinc finger protein 740 | 2 | 2 | ||||||||
MIRT463679 | YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | 2 | 2 | ||||||||
MIRT464111 | VPS35 | VPS35, retromer complex component | 2 | 2 | ||||||||
MIRT464413 | UNC13A | unc-13 homolog A | 2 | 6 | ||||||||
MIRT468614 | SUMO1 | small ubiquitin-like modifier 1 | 2 | 2 | ||||||||
MIRT469603 | RALGAPA2 | Ral GTPase activating protein catalytic alpha subunit 2 | 2 | 2 | ||||||||
MIRT469654 | RAC1 | Rac family small GTPase 1 | 2 | 2 | ||||||||
MIRT473288 | MFRP | membrane frizzled-related protein | 2 | 2 | ||||||||
MIRT473603 | MARK2 | microtubule affinity regulating kinase 2 | 2 | 2 | ||||||||
MIRT473660 | MARCKSL1 | MARCKS like 1 | 2 | 2 | ||||||||
MIRT474692 | KIF5A | kinesin family member 5A | 2 | 2 | ||||||||
MIRT475661 | HIC2 | HIC ZBTB transcriptional repressor 2 | 2 | 2 | ||||||||
MIRT477623 | EFNA1 | ephrin A1 | 2 | 2 | ||||||||
MIRT478124 | DIRAS1 | DIRAS family GTPase 1 | 2 | 2 | ||||||||
MIRT478440 | DAZAP2 | DAZ associated protein 2 | 2 | 4 | ||||||||
MIRT478949 | COX15 | COX15, cytochrome c oxidase assembly homolog | 2 | 2 | ||||||||
MIRT479970 | CARD10 | caspase recruitment domain family member 10 | 2 | 2 | ||||||||
MIRT480401 | C19orf47 | chromosome 19 open reading frame 47 | 2 | 2 | ||||||||
MIRT482808 | TRAF6 | TNF receptor associated factor 6 | 2 | 2 | ||||||||
MIRT482944 | ZNF561 | zinc finger protein 561 | 2 | 6 | ||||||||
MIRT483652 | QSOX2 | quiescin sulfhydryl oxidase 2 | 2 | 4 | ||||||||
MIRT485375 | MSN | moesin | 2 | 4 | ||||||||
MIRT485762 | B4GALT5 | beta-1,4-galactosyltransferase 5 | 2 | 2 | ||||||||
MIRT485924 | PGPEP1 | pyroglutamyl-peptidase I | 2 | 4 | ||||||||
MIRT486241 | FASTK | Fas activated serine/threonine kinase | 2 | 2 | ||||||||
MIRT486845 | SLC9A3R2 | SLC9A3 regulator 2 | 2 | 2 | ||||||||
MIRT486932 | DTX2 | deltex E3 ubiquitin ligase 2 | 2 | 2 | ||||||||
MIRT487111 | SCARF2 | scavenger receptor class F member 2 | 2 | 2 | ||||||||
MIRT487184 | NFASC | neurofascin | 2 | 4 | ||||||||
MIRT487209 | HMX1 | H6 family homeobox 1 | 2 | 2 | ||||||||
MIRT487319 | UBFD1 | ubiquitin family domain containing 1 | 2 | 4 | ||||||||
MIRT487810 | PER3 | period circadian clock 3 | 2 | 2 | ||||||||
MIRT487829 | CLSTN1 | calsyntenin 1 | 2 | 4 | ||||||||
MIRT488185 | MAT1A | methionine adenosyltransferase 1A | 2 | 2 | ||||||||
MIRT488638 | HAND2 | heart and neural crest derivatives expressed 2 | 2 | 2 | ||||||||
MIRT488845 | UBTF | upstream binding transcription factor, RNA polymerase I | 2 | 2 | ||||||||
MIRT489102 | ABCC5 | ATP binding cassette subfamily C member 5 | 2 | 4 | ||||||||
MIRT489222 | ASCL2 | achaete-scute family bHLH transcription factor 2 | 2 | 4 | ||||||||
MIRT489355 | SYNGR1 | synaptogyrin 1 | 2 | 4 | ||||||||
MIRT489730 | GNAI2 | G protein subunit alpha i2 | 2 | 4 | ||||||||
MIRT489771 | GRINA | glutamate ionotropic receptor NMDA type subunit associated protein 1 | 2 | 2 | ||||||||
MIRT490574 | SLC47A1 | solute carrier family 47 member 1 | 2 | 2 | ||||||||
MIRT490777 | PSMD3 | proteasome 26S subunit, non-ATPase 3 | 2 | 2 | ||||||||
MIRT491530 | HDAC5 | histone deacetylase 5 | 2 | 2 | ||||||||
MIRT492277 | SHISA6 | shisa family member 6 | 2 | 4 | ||||||||
MIRT492701 | PHYHIP | phytanoyl-CoA 2-hydroxylase interacting protein | 2 | 2 | ||||||||
MIRT493312 | LIMD2 | LIM domain containing 2 | 2 | 2 | ||||||||
MIRT493542 | ICOSLG | inducible T-cell costimulator ligand | 2 | 4 | ||||||||
MIRT494327 | CASKIN1 | CASK interacting protein 1 | 2 | 2 | ||||||||
MIRT494829 | ADCY9 | adenylate cyclase 9 | 2 | 2 | ||||||||
MIRT496770 | ADAMTS14 | ADAM metallopeptidase with thrombospondin type 1 motif 14 | 2 | 2 | ||||||||
MIRT496972 | RPS6KA2 | ribosomal protein S6 kinase A2 | 2 | 2 | ||||||||
MIRT497037 | DYRK1B | dual specificity tyrosine phosphorylation regulated kinase 1B | 2 | 2 | ||||||||
MIRT498912 | SRCAP | Snf2 related CREBBP activator protein | 2 | 2 | ||||||||
MIRT500013 | ABCF2 | ATP binding cassette subfamily F member 2 | 2 | 8 | ||||||||
MIRT502229 | HOXC6 | homeobox C6 | 2 | 2 | ||||||||
MIRT504106 | FLOT1 | flotillin 1 | 2 | 2 | ||||||||
MIRT506429 | NAGK | N-acetylglucosamine kinase | 2 | 6 | ||||||||
MIRT507335 | FAM168A | family with sequence similarity 168 member A | 2 | 2 | ||||||||
MIRT507780 | CDKN1B | cyclin dependent kinase inhibitor 1B | 2 | 2 | ||||||||
MIRT510061 | C12orf49 | chromosome 12 open reading frame 49 | 2 | 4 | ||||||||
MIRT511184 | MAPRE1 | microtubule associated protein RP/EB family member 1 | 2 | 2 | ||||||||
MIRT511934 | FAM127B | retrotransposon Gag like 8A | 2 | 2 | ||||||||
MIRT513517 | YIPF4 | Yip1 domain family member 4 | 2 | 6 | ||||||||
MIRT527161 | ADRA2B | adrenoceptor alpha 2B | 2 | 2 | ||||||||
MIRT535349 | PFN1 | profilin 1 | 2 | 2 | ||||||||
MIRT536733 | IER5 | immediate early response 5 | 2 | 4 | ||||||||
MIRT539178 | AP1G1 | adaptor related protein complex 1 gamma 1 subunit | 2 | 2 | ||||||||
MIRT544642 | PHF8 | PHD finger protein 8 | 2 | 4 | ||||||||
MIRT553367 | TRIM44 | tripartite motif containing 44 | 2 | 2 | ||||||||
MIRT568466 | ARMC12 | armadillo repeat containing 12 | 2 | 2 | ||||||||
MIRT568970 | CACNA1C | calcium voltage-gated channel subunit alpha1 C | 2 | 2 | ||||||||
MIRT569008 | CXorf36 | chromosome X open reading frame 36 | 2 | 2 | ||||||||
MIRT569036 | IL21R | interleukin 21 receptor | 2 | 2 | ||||||||
MIRT569720 | GPR173 | G protein-coupled receptor 173 | 2 | 2 | ||||||||
MIRT569866 | KLK10 | kallikrein related peptidase 10 | 2 | 2 | ||||||||
MIRT569913 | PCSK9 | proprotein convertase subtilisin/kexin type 9 | 2 | 2 | ||||||||
MIRT570011 | COL1A2 | collagen type I alpha 2 chain | 2 | 2 | ||||||||
MIRT570059 | CPNE2 | copine 2 | 2 | 2 | ||||||||
MIRT570306 | GOSR1 | golgi SNAP receptor complex member 1 | 2 | 2 | ||||||||
MIRT570724 | CELSR2 | cadherin EGF LAG seven-pass G-type receptor 2 | 2 | 2 | ||||||||
MIRT570981 | RGS19 | regulator of G protein signaling 19 | 2 | 2 | ||||||||
MIRT571195 | C9orf62 | chromosome 9 open reading frame 62 | 2 | 2 | ||||||||
MIRT572264 | AGO2 | argonaute 2, RISC catalytic component | 2 | 2 | ||||||||
MIRT573214 | NAT10 | N-acetyltransferase 10 | 2 | 2 | ||||||||
MIRT574022 | RIMBP3C | RIMS binding protein 3C | 2 | 2 | ||||||||
MIRT574393 | TMEM109 | transmembrane protein 109 | 2 | 2 | ||||||||
MIRT574632 | LPCAT3 | lysophosphatidylcholine acyltransferase 3 | 2 | 2 | ||||||||
MIRT574689 | HNRNPA3 | heterogeneous nuclear ribonucleoprotein A3 | 2 | 2 | ||||||||
MIRT621600 | USF2 | upstream transcription factor 2, c-fos interacting | 2 | 2 | ||||||||
MIRT631302 | CBS | cystathionine-beta-synthase | 2 | 2 | ||||||||
MIRT647749 | SAMD9L | sterile alpha motif domain containing 9 like | 2 | 2 | ||||||||
MIRT649338 | HEXA | hexosaminidase subunit alpha | 2 | 2 | ||||||||
MIRT649993 | MSI1 | musashi RNA binding protein 1 | 2 | 2 | ||||||||
MIRT661785 | NLRC3 | NLR family CARD domain containing 3 | 2 | 2 | ||||||||
MIRT665991 | SYNJ2BP | synaptojanin 2 binding protein | 2 | 2 | ||||||||
MIRT667176 | NR2F6 | nuclear receptor subfamily 2 group F member 6 | 2 | 4 | ||||||||
MIRT667385 | MOB1B | MOB kinase activator 1B | 2 | 2 | ||||||||
MIRT669206 | CBX8 | chromobox 8 | 2 | 2 | ||||||||
MIRT680928 | EVC | EvC ciliary complex subunit 1 | 2 | 2 | ||||||||
MIRT691869 | GXYLT2 | glucoside xylosyltransferase 2 | 2 | 2 | ||||||||
MIRT693257 | HBS1L | HBS1 like translational GTPase | 2 | 2 | ||||||||
MIRT693489 | MOB3A | MOB kinase activator 3A | 2 | 2 | ||||||||
MIRT699480 | SLC10A6 | solute carrier family 10 member 6 | 2 | 2 | ||||||||
MIRT717096 | PXDC1 | PX domain containing 1 | 2 | 2 | ||||||||
MIRT717121 | SOWAHA | sosondowah ankyrin repeat domain family member A | 2 | 2 | ||||||||
MIRT717642 | HLX | H2.0 like homeobox | 2 | 2 | ||||||||
MIRT722584 | THBS2 | thrombospondin 2 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|